Ameritas Investment Partners’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
Other funds holding REPL
BBA
RI
RCI
SCM
BCM
FIS
Ameritas Investment Partners's REPL Position: Q2 2026 in Review
Ameritas Investment Partners increased its Replimune Group (REPL) stake by 17% in Q2 2026, buying an estimated $6.25K and bringing the position to 7,188 shares worth $79.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1977.
Ameritas Investment Partners first reported a position in REPL in Q3 2018 and has held it in 32 quarters since. The position peaked at $87.6K in Q4 2022. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.
- Ameritas Investment Partners held 7,188 shares of Replimune Group worth $79.6K as of Q2 2026.
- Ameritas Investment Partners bought 1,021 Replimune Group shares in Q2 2026, an estimated $6.25K.
- Replimune Group made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1977 holding.
- Ameritas Investment Partners first reported a position in Replimune Group in Q3 2018 and has held it in 32 quarters since.
- Ameritas Investment Partners's Replimune Group position peaked at $87.6K in Q4 2022.
- 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.